Dr. Sadri ZNAIDI is a biochemist (B.Sc., M.Sc. from the University of Sherbrooke, Canada) and molecular biologist (Ph.D., from the University of Montreal, Canada), with expertise in yeast genetics and functional genomics. He is currently a RIIP (Institut Pasteur International Network) Affiliate Program Fellow, with affiliations at the Institut Pasteur in Tunis and Paris. His current work focuses on the implementation of systems biology-oriented approaches to identify and characterize components of the biological circuitry involved in the interaction of Candida albicans with the host environment.
Implementation of an NGS core facility at Institut Pasteur of Tunis: Biomics as capacity building model
Between 2018 and 2022, and as Biomics project manager, I contributed to a large capacity building in Pathogen-Host Interaction Data access project (PHINDaccess) which is coordinated by the Institut Pasteur de Tunis (IPT) and […]
Candida albicans colonization of abiotic and biotic surfaces
Biofilms formed by C. albicans on indwelling devices play a major role in the persistence of nosocomial infections, largely because of their elevated tolerance to antifungals. The Fungal Biology and Pathogenicity Unit at Institut […]
Regulation of Candida albicans morphogenesis
The Fungal Biology and Pathogenicity Unit at Institut Pasteur is interested in the regulation of the yeast-to-hypha transition in C. albicans because of its role in biofilm formation and, more generally, in virulence. While […]
FunComPath is a network within the Infect-ERA programme (www.infect-era.eu). Infect-ERA is an ERA-Net on human infectious diseases funded under the EU 7th Research Framework Programme (2013 – 2016). It is a continuation of the […]
Current: RIIP Affiliate Program Fellow, Institut Pasteur in Tunis & Paris
2010 – 2015: Postdoctoral fellow, Institut Pasteur, Paris, France
2004 – 2010: Ph.D., Molecular Biology, University of Montreal, Canada
2002 – 2004: M.Sc., Biochemistry, Université de Sherbrooke, Canada
1999 – 2002: B.Sc., Biochemistry, Université de Sherbrooke, Canada
2022Functional Portrait of Irf1 (Orf19.217), a Regulator of Morphogenesis and Iron Homeostasis in Candida albicans., Front Cell Infect Microbiol 2022 ; 12(): 960884.
2021Ethylzingerone, a Novel Compound with Antifungal Activity., Antimicrob Agents Chemother 2021 03; 65(4): .
2021High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis., J Fungi (Basel) 2021 Feb; 7(3): .
2020A conserved regulator controls asexual sporulation in the fungal pathogen Candida albicans., Nat Commun 2020 12; 11(1): 6224.
2020mSphere of Influence: Decoding Transcriptional Regulatory Networks To Illuminate the Mechanisms of Microbial Pathogenicity., mSphere 2020 01; 5(1): .
2020Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans., Front Microbiol 2020 ; 11(): 591140.
2019From Genes to Networks: The Regulatory Circuitry Controlling Candida albicans Morphogenesis., Curr Top Microbiol Immunol 2019 ; 422(): 61-99.
2018A conserved fungal hub protein involved in adhesion and drug resistance in the human pathogen Candida albicans., Cell Surf 2018 Dec; 4(): 10-19.
2018Systematic gene overexpression in Candida albicans identifies a regulator of early adaptation to the mammalian gut., Cell Microbiol 2018 Nov; 20(11): e12890.
2018Generating genomic platforms to study Candida albicans pathogenesis., Nucleic Acids Res 2018 08; 46(14): 6935-6949.
+View full list of publications